Table 1.
N = 109 | |
---|---|
Age(years) | 52.9 ± 10.1 |
Sex, n (%) | |
Male | 66 (60.6%) |
Female | 43 (39.4%) |
Duration of ALS symptoms (mo) | 15.6 ± 9.7 |
Bulbar onset, n (%) | 36 (33.0%) |
ALSFRS-R score | 40.2 ± 4.2 |
ALSSS | 10.3 ± 1.7 |
Poor sleeper, n (%) | 68 (62.3%) |
EDS, n (%) | 17 (15.6%) |
RBD, n (%) | 11 (10.1%) |
Anxiety, n (%) | 29 (16.6%) |
Depression, n (%) | 43 (39.4%) |
Riluzole, n (%) | 44 (40.3%) |
ALS, Amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, Amyotrophic Lateral Sclerosis Severity Scale; EDS, excessive daytime sleepiness; RBD, REM sleep behavior disorder. Values of continuous variables are reported as mean value ± standard deviation and categorical variables are reported as number of cases and proportions.